As of 2025-12-23, the Intrinsic Value of Akero Therapeutics Inc (AKRO) is -17.79 USD. This AKRO valuation is based on the model Peter Lynch Fair Value. With the current market price of 54.65 USD, the upside of Akero Therapeutics Inc is -132.54%.
Based on its market price of 54.65 USD and our intrinsic valuation, Akero Therapeutics Inc (AKRO) is overvalued by 132.54%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.79 - -17.79 | -17.79 | -132.54% |
| P/E | (46.46) - (74.49) | (64.03) | -217.2% |
| DDM - Stable | (33.72) - (130.91) | (82.32) | -250.6% |
| DDM - Multi | (0.48) - (1.40) | (0.71) | -101.3% |
| Market Cap (mil) | 4,498.79 |
| Beta | 0.13 |
| Outstanding shares (mil) | 82.32 |
| Enterprise Value (mil) | 4,322.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.91% |
| Cost of Debt | 5.00% |
| WACC | 8.87% |